Inglis Tiffany Eul Davis
SEC CIK 2091798 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SERA | SERA PROGNOSTICS, INC. | Chief Medical Off | 91.6K | — | $1,700 | 4 | 2025-10-15 | 2026-09-10 |
Most active insiders at SERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lindgardt Zhenya | CEO, Dir | — | $290.5K |
| 2 | Kearney Paul | Chief Data Off | — | $131.0K |
| 3 | Aerts Austin | CFO | — | $65.8K |
| 4 | Harrison Robert Gardner | CIO | — | $62.2K |
| 5 | Jackson Benjamin | GC | — | $38.4K |
| 6 | Boniface John J. | CSO | — | $33.8K |
| 7 | Anderson Dyaarl Lee Jr. | Chief Commercial Off | — | $13.1K |
| 8 | Lawrence Sandra AJ | Dir | — | $11.2K |
| 9 | Mirza Mansoor Raza | Dir | — | $2,280 |
| 10 | Inglis Tiffany Eul Davis | Chief Medical Off | — | $1,700 |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 16:07 | 2026-09-10 | SERA | SERA PROGNOSTICS, INC. | Inglis Tiffany Eul Davis | Chief Medical Off | S - Sale | $2.00 | -486 | 91.6K | -0.5% | -$972 | |
| 2026-06-15 16:08 | 2026-06-11 | SERA | SERA PROGNOSTICS, INC. | Inglis Tiffany Eul Davis | Chief Medical Off | S - Sale | $2.01 | -362 | 92.1K | -0.4% | -$727.62 | |
| D | 2026-03-13 | 2026-03-12 | SERA | SERA PROGNOSTICS, INC. | Inglis Tiffany Eul Davis | Chief Medical Off | A - Grant | $0.00 | +17.4K | 92.4K | +23% | $0 |
| D | 2025-10-15 | 2025-10-15 | SERA | SERA PROGNOSTICS, INC. | Inglis Tiffany Eul Davis | Chief Medical Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations